Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

5 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	4,818	4,906	2,915	5,293	6,963	10,520	10,772	9,796
EBITDA	-124	55	165	1,287	2,203	2,862	2,902	1,659
Net profit	-97	-48	143	1,258	2,103	2,261	2,734	1,416
Total assets	1,588	1,387	1,049	2,967	7,003	9,544	10,151	9,917
n (companies reporting)	2	2	2	2	4	4	4	4

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Vorld Pharma	—	—	—	—	0	2,457	4,507	2,701
Ortojorjia	—	—	—	—	0	2,214	2,150	2,676
Kalandadze	0	2,521	2,915	3,049	3,146	2,866	2,177	2,312
SBC Global	—	—	0	2,245	3,818	2,983	1,939	2,106
Geo - Pharma	4,818	2,385	—	—	—	—	—	—

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Peer coverage varies by year — FY2017–FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.